These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 33495064

  • 1. A Multicenter Global Registry of Paclitaxel Drug-Coated Balloon in Dysfunctional Arteriovenous Fistulae and Grafts: 6-Month Results.
    Karnabatidis D, Kitrou PM, Ponce P, Chong TT, Pietura R, Pegis JD, Ko PJ, Lin CH, Lutonix AV Global Registry Investigators.
    J Vasc Interv Radiol; 2021 Mar; 32(3):360-368.e2. PubMed ID: 33495064
    [Abstract] [Full Text] [Related]

  • 2. Safety and Efficacy of Paclitaxel-Eluting Balloon Angioplasty for Dysfunctional Hemodialysis Access: A randomized trial Comparing with Angioplasty Alone.
    Therasse E, Caty V, Gilbert P, Giroux MF, Perreault P, Bouchard L, Oliva VL, Lespérance J, Ethier J, Ouellet G, Francoeur M, Cournoyer S, Soulez G.
    J Vasc Interv Radiol; 2021 Mar; 32(3):350-359.e2. PubMed ID: 33483226
    [Abstract] [Full Text] [Related]

  • 3. Drug Coated Balloons for Dysfunctional Haemodialysis Venous Access: A Patient Level Meta-Analysis of Randomised Controlled Trials.
    Fong KY, Zhao JJ, Tan E, Syn NL, Sultana R, Zhuang KD, Chua JME, Patel A, Irani FG, Tay KH, Tan BS, Too CW.
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):610-621. PubMed ID: 34362627
    [Abstract] [Full Text] [Related]

  • 4. The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis.
    Trerotola SO, Saad TF, Roy-Chaudhury P, Lutonix AV Clinical Trial Investigators.
    J Vasc Interv Radiol; 2020 Jan; 31(1):1-14.e5. PubMed ID: 31706886
    [Abstract] [Full Text] [Related]

  • 5. A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access.
    Chen X, Liu Y, Wang J, Zhao J, Singh N, Zhang WW.
    J Vasc Surg; 2020 Dec; 72(6):2186-2196.e3. PubMed ID: 32540324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single-Center Prospective Pilot Study of Sirolimus Drug-Coated Balloon Angioplasty in Maintaining the Patency of Thrombosed Arteriovenous Graft.
    Tan CW, Tan RY, Pang SC, Tng ARK, Tang TY, Zhuang KD, Chua JME, Tay KH, Chong TT, Tan CS.
    J Vasc Interv Radiol; 2021 Mar; 32(3):369-375. PubMed ID: 33334667
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paclitaxel-Coated Balloons for the Treatment of Dysfunctional Dialysis Access. Results from a Single-Center, Retrospective Analysis.
    Kitrou PM, Spiliopoulos S, Papadimatos P, Christeas N, Petsas T, Katsanos K, Karnabatidis D.
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):50-54. PubMed ID: 27738819
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial.
    Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D.
    J Endovasc Ther; 2012 Apr; 19(2):263-72. PubMed ID: 22545894
    [Abstract] [Full Text] [Related]

  • 15. Drug-coated balloon for early recurrent arteriovenous fistula dysfunction.
    Hsin CH, Yang HT, Feng PC, Su TW, Yu SY, Ko PJ.
    J Vasc Access; 2024 Sep; 25(5):1560-1566. PubMed ID: 37309828
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial.
    Karunanithy N, Mesa IR, Dorling A, Calder F, Katsanos K, Semik V, Robinson E, Peacock J, Das N, Forman C, Lawman S, Steiner K, Wilkins CJ, Robson MG.
    Trials; 2016 May 12; 17(1):241. PubMed ID: 27175481
    [Abstract] [Full Text] [Related]

  • 19. Use of Drug-Coated Balloons in Dysfunctional Arteriovenous Dialysis Access Treatment: The Effect of Consecutive Treatments on Lesion Patency.
    Kitrou PM, Katsanos K, Spyridonidis I, Theofanis M, Papachristou E, Papadoulas S, Karnabatidis D.
    J Vasc Interv Radiol; 2019 Feb 12; 30(2):212-216. PubMed ID: 30717952
    [Abstract] [Full Text] [Related]

  • 20. Polymer-coated paclitaxel-eluting stents for the treatment of stenosed native arteriovenous fistulas: Long-term results from the ELUDIA study.
    Katsanos K, Ho P, Tang TY, Vlachou E, Yap CJQ, Kitrou PM, Karnabatidis D.
    J Vasc Access; 2024 Sep 12; 25(5):1593-1600. PubMed ID: 37341208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.